Skip to content

Chinese American Family Caregiver Writing Study

Chinese American Family Caregiver Writing Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05087576
Enrollment
67
Registered
2021-10-21
Start date
2020-10-01
Completion date
2022-09-18
Last updated
2022-11-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mental Health Issue

Brief summary

The Chinese American Family Caregiver Writing Study is a Randomized Controlled Trial (RCT) testing the efficacy of the Expressive Helping (EH) intervention among Chinese Americans who are providing care for family members undergoing cancer treatment.

Detailed description

Because the psychosocial health of Chinese cancer patients and their caregivers are linked, there is a need to improve health outcomes for not just the patients, but also for the caregivers. While many caregiving interventions have focused on the caregiver-patient dyad as the the unit of care, interventions that solely target caregivers are crucial given the emotional, social, financial, and physical toll of caregiving. To address this need, investigators are testing a writing intervention, Expressive Helping (EH), with Chinese family members who are providing care for their family members diagnosed with cancer. Over four brief structured writing sessions, participants write about their cancer caregiving experiences, disclosing their emotions and providing encouragement and guidance, with the knowledge that their narratives will be shared with and used as a resource for other Chinese cancer caregivers. Participants will be adult cancer caregivers of Chinese descent. After screening and consent, eligible participants will be enrolled in a 1:1 randomized controlled trial. Assessments of psychological symptoms will occur at baseline (prior to randomization), 1-month post-intervention, and 3-month post-intervention. Investigators will also assess potential mediators and moderators of the potential intervention effects. Investigators interacting with the participants will be blind to condition assignment.

Interventions

Expressive helping integrates two distinct areas of research showing that emotional disclosure over writing and support giving improves psychological well-being among healthy and clinical populations. Participants write 4 brief structured writing sessions.

BEHAVIORALCaregiving Fact writing

Factual Writing has been used with in other writing-based interventions (e.g., expressive writing). It is also completed in 4 brief structured writing sessions.

Sponsors

New York University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Over 18 years old * Of Chinese descent * Informal (i.e., uncompensated) caregiver of individual diagnosed with cancer

Exclusion criteria

* Inability to read or write English or Traditional/Simplified Chinese

Design outcomes

Primary

MeasureTime frameDescription
Changes in depressive symptoms assessed by the Center for Epidemiologic Studies Depression ScaleBaseline to 1-month follow-up and 3-month follow-upDepressive symptoms will be measured with the 20-item Center for Epidemiologic Studies Depression Scale (CES-D). Score ranges from 0-60, with higher scores indicating a worse outcome.
Changes in life satisfaction assessed by the Satisfaction with Life Scale.Baseline to 1-month follow-up and 3-month follow-upLife satisfaction will be measured by the 5-item Satisfaction with Life Scale (SWLS). Score ranges from 5-35, with higher scores indicating a better outcome.
Changes in caregiver quality of life assessed by the Caregiver quality of life index - CancerBaseline to 1-month follow-up and 3-month follow-upCaregiver quality of life will be measured by the 35 item Caregiver quality of life index - Cancer (CQOL-C). Score ranges from 0-140, with higher scores indicating a worse outcome.

Secondary

MeasureTime frameDescription
Changes in post-traumatic growth assessed by the Post-traumatic Growth InventoryBaseline to 1-month follow-up and 3-month follow-upPost-traumatic growth will be measured by the 21-item Post-traumatic Growth Inventory (PTGI). Score ranges from 0-105, with higher scores indicating a better outcome.
Changes in intrusive thoughts assessed by the Impact of Event scale.Baseline to 1-month follow-up and 3-month follow-upIntrusive thoughts will be measured by the 15 item Impact of Event scale (IES). Score ranges from 0-40, with higher scores indicating a worse outcome.
Changes in sleep quality assessed by the Pittsburgh Sleep Quality IndexBaseline to 1-month follow-up and 3-month follow-upSleep quality will be measured by the 19-item Pittsburgh Sleep Quality Index (PSQI). Score ranges from 0-21, with higher scores indicating a worse outcome.
Changes in caregiver strain assessed by the Zarit Burden InterviewBaseline to 1-month follow-up and 3-month follow-upCaregiver strain will be measured by the 22-item Zarit Burden Interview. Score ranges from 0-88, with higher scores indicating a worse outcome.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026